RECURSION PHARMACEUTICALS-A (RXRX)

US75629V1044 - Common Stock

10.0701  -0.1 (-0.98%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
44.58M39.84M10.18M3.96M2.32M
Cost Of Goods
42.59M48.28MN/AN/AN/A
Gross Profit
1.99M-8.43MN/AN/AN/A
Operating Expenses
350.85M237.29M192.95M88.58M64.76M
Research and Development
208.37M141.27M125.98M61.54M44.86M
Selling, General, and Administrative Expenses
133.98M95.65M66.67M27.04M19.90M
Operating Income
-348.86M-245.73M-182.77M-84.62M-62.44M
Interest Income/Expense
19.02M6.20M-2.88M-1.02M1.11M
Other Income/Expense
-1.09M50.00K0.00-480.00K10.00K
Non Recurring Items
-1.20M0.00-830.00K-880.00K-560.00K
Income Before Taxes
-332.13M-239.48M-186.48M-87.01M-61.88M
Income Tax
-4.06MN/AN/AN/AN/A
Net Income
-328.07M-239.48M-186.48M-87.01M-61.88M
EBITDA
-324.46M-233.97M-174.36M-80.18M-58.90M
 
Per Share Data
EPS Diluted Total Ops
-1.58-1.36-1.49-0.54-0.38
Non GAAP EPS
-1.57-1.37N/AN/AN/A
 
Statistics
Gross Profit Margin
4.46%-21.16%N/AN/AN/A
Profit Margin
-735.99%-601.10%-1831.83%-2197.22%-2667.24%
Operating Profit Margin
-782.64%-616.79%-1795.38%-2136.87%-2691.38%

All data in USD

Charts